Announcing changes to Cambridge Clinical Laboratories senior team
Dr Anthony Cooke with new CCL CEO, Jonathan Shrewsbury
Dr Anthony Cooke, who has guided CCL as CEO since 2019, has decided to step back from his CEO role to start his journey to retirement. He will remain part of the private lab’s senior leadership team, staying on as Chief Scientific Officer. Joining the helm is Jonathan Shrewsbury who will take on the role of CEO, and work in partnership with Tony to build the future of CCL.
Dr Anthony Cooke (Tony)
Chief Scientific Officer
Tony was a founding member of, what is now known as, CCL in 2005. With nearly 40 years’ experience in the diagnostics industry, his loyalty and relationship with the company has seen him a steadfast figure guiding CCL to where they are now.
Tony has driven diagnostic innovation, developed relationships with diagnostic and pharmaceutical companies, and expanded the offering to the NHS.
During 2020, Tony was a key supporter and advisor to the Covid-19 Volunteer Testing Network, and became a key spokesperson on Covid testing in the global media. On reflection of his impact during Covid he has been awarded the role of Scientific Advisory Board Chair for the Laboratory and Testing Industry Organisation - the trade association for the testing industry, covering testing companies and laboratories.
Jonathan Shrewsbury
Chief Executive Officer
Jonathan has enjoyed a 30-year career in the healthcare sector. Starting out in NHS physiotherapy, and moving on to travelling the world for ten years in elite sport.
His journey into business and management started in 2006 when he joined forces with Medical Diagnostic Imaging Ltd and co-founded Sports Orthopaedics Spinal Ltd - one of the largest independent teams of musculoskeletal specialists in the UK.
He has also held management roles at Virgin Care, and co-founded Prime Health Diagnostics Ltd - where he worked with esteemed clients such as Premier League Football Clubs, Premiership Rugby Clubs, England RFU, TeamGB, English Institute of Sport and the European Tour.
More recently Jonathan has consulted on numerous healthcare projects both in the UK and globally for private clients, healthcare businesses, private equity, corporate finance companies, doctor groups, elite sports clubs and global brands.
CCL CEO, Jonathan Shrewsbury, said: “I’m delighted to join CCL. When I met Tony I felt an immediate sense of warmth, togetherness and professionalism and I have quickly seen what a force of nature he is in the lab world. I look forward to working alongside him. I am excited to support the dedicated CCL team as we launch new tests and innovations to support the oncology pathways in the UK, and use my business and healthcare experience to help to commercialise CCL in other ways.”
CCL Chief Scientific Officer, Dr Anthony Cooke, adds: “The last few years have been rewarding and exciting, but a lot of hard work during the Covid pandemic. Having Jonathan come on board as we shape the future of CCL is not only a great benefit to me, but the synergy he brings to the team, with his medical experience, moves us into a new dimension. I very much look forward to working closely with Jonathan to continue to find and commercialise new cutting edge diagnostics in the UK.”
Media: For further information and to speak to Jonathan and/or Tony please contact Kelly Morel, PR Manager, kelly@happycommunications.co.uk